Mitoxantrone hydrochloride is approved to be used with other drugs to treat: Acute myeloid leukemia (AML) and prostate cancer. It is used as palliative treatment in advanced disease that is hormone-refractory (does not respond to hormone treatment).
Mitoxantrone hydrochloride is also being studied in the treatment of other types of cancer. Mitoxantrone also displays broad immunosuppressive activity inhibiting proliferation of all classes of lymphocytes and inducing apoptosis of antigen-presenting T cells.
API's & Drug Standards
Cancer Research and Antivirals
|Formula||C22H28N4O6 · 2HCl|
Send us your enquiry for Mitoxantrone Hydrochloride. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Mitoxantrone Hydrochloride email us and we will include your contribution on the website.